Aptamers Market is anticipated to reach USD 8.91 billion by 2025. Aptamers implies peptide or oligonucleotides molecules that bind to target protein, nucleic acid, lipid molecules with a high specificity. Rapidly generated Aptamers are applied for specific detection, characterization, and inhibition of proteins. They have several characteristics and could be used as pharmaceutical leads, detection reagents, small molecules, efficient proteomic stages with antibodies, and the other aptamers.
The
factors that propel the growth of the aptamers industry include strong trend of
R&D savings in pharmaceutical and biotechnology industries, technological
advancements, patent expiration of systematic development of ligands by
exponential improvement technology (SELEX), and the low price and high
productivity of aptamers in binding to large molecules as related to
antibodies. On the other hand, there are factors that may hamper the growth of
the market including low awareness of technology, and low-income countries.
Aptamers Market is anticipated to grow at a significant CAGR of 28.2% in the
upcoming period as the scope, product types, and its applications are
increasing across the globe.
Request Sample Copy of This Market Research @
https://www.millioninsights.com/industry-reports/aptamers-market/request-sample
Aptamers
industry may be explored by type, technology, application, end user, and
geography. The market may be explored by type as XNA-Based Aptamers, and
DNA-Based Aptamers, RNA-Based Aptamers. The “DNA-based Aptamers” segment led
the market in 2016 and is anticipated to maintain its dominance by 2025; even
though XNA-based aptamers will increase at the highest CAGR between 2015 and
2025 owing to increase in demand for nucleic acid-based diagnostic therapeutics
and kits across the globe.
The
key applications that could be explored in the aptamers market include Research
and Development, Therapeutics Development, Diagnostics, and Other Applications.
The “Diagnostics” segment led the market in 2016 and is anticipated to maintain
its dominance by 2025 owing to introduction of novel diagnostic kits by major
companies.
The
aptamers industry could be explored based on end user as Contract Research
Organizations, Biotechnology and Pharmaceutical Companies, Academic and
Government Research Institutes, and Other End Users. The “Academic And
Government Research Institutes” segment led the market in 2016 and is
anticipated to maintain its dominance by 2025 followed by Biotechnology and
Pharmaceutical Companies segment. The industry may be analyzed by technology as
SELEX, and Other Technologies. The “Other Technologies” segment led the market
in 2015 and is anticipated to maintain its dominance by 2025.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/aptamers-market
North
America accounted for the major share of the aptamers market size in 2016 and
will continue to lead in the forecast period. The factors that could be
attributed to the growth include increasing number of companies coupled with
increasing R&D activities in this area, and continuous technological
advancements in technologies, growing number of research laboratories and
promising government initiatives.
Some
of the key players that fuel the growth of the aptamers industry comprise
Aptamer Group, Somalogic Inc., Aptamer Sciences Inc., Aptagen LLC, Noxxon
Pharma, Base Pair Biotechnologies Inc., Vivonics Inc, etc. The leading
companies are taking up partnerships, mergers and acquisitions, and joint
ventures in order to boost the inorganic growth of the industry.
Comments
Post a Comment